The most common clinical manifestations of bladder cancer

Written by Zhou Zi Hua
Oncology
Updated on September 07, 2024
00:00
00:00

The most common clinical manifestations of bladder cancer include: one initial clinical presentation is hematuria, which typically appears as painless, intermittent gross hematuria, sometimes it can also manifest as microscopic hematuria. The hematuria may occur only once or last from one day to several days, and it can subside or stop on its own. The color of the hematuria can be light red, possibly dark brown, generally dark red. The amount of bleeding and the duration of the hematuria are not necessarily proportional to the malignancy degree, size, scope, and number of the tumor. Additionally, bladder cancer patients can experience symptoms of bladder irritation, such as frequent urination, urgent urination, painful urination, and difficulties in urination, etc.

Other Voices

doctor image
home-news-image
Written by Hu Zhong Dong
Medical Oncology
1min 4sec home-news-image

Is hematuria in bladder cancer a late stage symptom?

Bladder cancer is a relatively common malignant tumor of the urinary system, with over 70% of bladder cancers presenting with hematuria in the early stages. However, about 10% of bladder cancer patients do not exhibit hematuria. For instance, when the bladder cancer is infiltrative, it is less likely to bleed, and when bleeding does occur, it is usually in the advanced stages. Frequent urination, painful urination, blood in urine, and cloudy urine can all be early signs of bladder issues. If someone experiences these symptoms, it is crucial to go to the hospital for relevant examinations early to detect bladder cancer at an early stage. Additionally, it is advisable not to hold in urine, to smoke less or quit smoking, and to drink more water to reduce the incidence of bladder cancer.

doctor image
home-news-image
Written by Liu Liang
Oncology
51sec home-news-image

Is the bladder cancer embryonic antigen high?

Carcinoembryonic antigen (CEA) is significantly elevated, mainly seen in gastrointestinal tumors, especially in colorectal cancers such as colon and rectal cancers, where CEA elevation is more pronounced. It can also be notably higher in patients with lung adenocarcinoma, and bladder cancer might show an increase in CEA as well. However, the increase in CEA is not necessarily consistent, and its diagnostic value for bladder cancer is limited due to low specificity and sensitivity, making it not very instructive. The definitive diagnosis of bladder cancer primarily involves cystoscopy and taking a biopsy to confirm the presence of cancer.

doctor image
home-news-image
Written by Guan Hai Fang
Urology
46sec home-news-image

Is bladder cancer contagious?

Bladder cancer is not contagious, so there is no need to worry about that. Bladder cancer occurs when there is a cancerous transformation of bladder tissue, leading to the formation of bladder tumors. If the tumors are malignant, they are generally termed bladder cancer. Causes of bladder cancer can include long-term exposure to certain carcinogens, such as occupations involving dyes, leather, or paintwork. Another carcinogenic factor is smoking, which is related to about one-third of bladder cancer cases. Chronic infection or prolonged irritation by foreign bodies can also increase the risk of bladder cancer, as seen in cases with bladder stones, bladder diverticula, or chronic cystitis.

doctor image
home-news-image
Written by Shen Jiang Chao
Radiology
56sec home-news-image

Can bladder cancer be detected by color ultrasound?

Bladder cancer can be detected by color ultrasound. Bladder cancer is one of the most common tumors in the urinary system, and its typical clinical manifestation is painless gross hematuria, often occurring in the bladder trigone area. Normally, the bladder appears as an echo-free spherical shadow on ultrasound. If one sees one or more papillary or cauliflower-like moderate echoes protruding into the cavity within the echo-free area, with a wide base of the tumor, varying tumor sizes, rough surfaces, and no movement with the change of body position, bladder cancer should be considered. Early bladder cancer is characterized by localized thickening of the bladder wall and disappearance of the normal structure of the bladder wall. On CDFI (Color Doppler Flow Imaging), blood flow signals can be observed at the base of the tumor.

doctor image
home-news-image
Written by Liu Liang
Oncology
30sec home-news-image

What medicine is infused into the bladder for bladder cancer?

Postoperative intravesical chemotherapy infusion is very common in the treatment of bladder cancer. Common drugs used for infusion chemotherapy include mitomycin and anthracyclines such as epirubicin or pirarubicin. Gemcitabine is also frequently used for this purpose. The related side effects generally include irritation symptoms of the bladder, although some patients may experience relatively mild side effects.